Supernus PharmaceuticalsSUPN
那斯達克 · USD
35.51
+0.41
(+1.15%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Supernus PharmaceuticalsSUPN
35.51
+0.41
(+1.15%)
財務數據
損益表
- 1.67
- 1.54
- 1.36
- 1.54
- 1.64
- 1.44
- 1.68
- 1.76
- 1.74
- 1.50
- -5.65
- -8.11
- -11.84
- 13.51
- 6.78
- -12.58
- 17.18
- 4.37
- -0.87
- -13.97
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 149,824 | 174,159 | 175,689 | 168,325 | 143,644 | 164,314 | 153,880 | 135,563 | 153,764 | 167,328 |
營業成本 | 15,763 | 26,098 | 17,583 | 17,916 | 16,309 | 19,627 | 19,601 | 21,091 | 23,460 | 22,954 |
營業毛利 | 134,061 | 148,061 | 158,106 | 150,409 | 127,335 | 144,687 | 134,279 | 114,472 | 130,304 | 144,374 |
營業費用 | 144,317 | 126,656 | 117,261 | 127,840 | - | 145,683 | 126,141 | 132,059 | 125,128 | 110,040 |
研發費用 | 26,927 | 28,647 | 29,036 | 26,183 | 24,930 | 23,347 | 22,655 | 24,379 | 21,212 | 17,774 |
推銷及管理費用 | 97,604 | 79,765 | 68,737 | 81,549 | 85,421 | 81,078 | 82,244 | 87,572 | 83,950 | 71,568 |
非經常性項目費用 | - | - | - | - | - | 20,189 | - | - | - | - |
其他營業費用 | 19,786 | 18,244 | 19,488 | 20,108 | 20,137 | 21,069 | 21,242 | 20,108 | 19,966 | 20,698 |
營業利益 | -10,256 | 21,405 | 40,845 | 22,569 | -3,153 | -996 | 8,138 | -17,587 | 5,176 | 34,334 |
其他收入及費用 | 4,425 | 4,977 | 4,098 | 3,733 | 3,396 | 1,986 | 1,751 | 1,370 | 5,346 | 2,400 |
利息費用 | - | - | - | - | - | - | - | 910 | 1,505 | 1,594 |
稅前純益 | -5,831 | 26,382 | 44,943 | 26,302 | 243 | 990 | 9,889 | -17,127 | 9,017 | 35,140 |
所得稅 | 5,996 | 11,054 | 6,446 | 6,386 | 119 | -185 | 25,865 | -16,296 | -7,931 | 9,659 |
稅後純益 | -11,827 | 15,328 | 38,497 | 19,916 | 124 | 1,175 | -15,976 | -831 | 16,948 | 25,481 |
基本每股稅後盈餘(元) | -0.21 | 0.28 | 0.70 | 0.36 | 0.00 | - | -0.29 | -0.02 | 0.31 | 0.47 |
稀釋每股稅後盈餘(元) | -0.21 | 0.27 | 0.69 | 0.36 | 0.00 | 0.02 | -0.29 | 0.00 | 0.29 | 0.42 |
基本平均股數(千股) | 55864.00 | 55465.00 | 55149.00 | 54978.00 | 54801.00 | - | 54608.00 | 54502.00 | 54380.00 | 54104.00 |
稀釋平均股數(千股) | 55864.00 | 56464.00 | 56016.00 | 55724.00 | 55626.00 | - | 54608.00 | 54502.00 | 62454.00 | 62087.00 |
還原基本每股稅後盈餘(元) | -0.21 | 0.28 | 0.70 | 0.36 | 0.00 | - | -0.29 | -0.02 | 0.31 | 0.47 |
還原稀釋每股稅後盈餘(元) | -0.21 | 0.27 | 0.69 | 0.36 | 0.00 | 0.02 | -0.29 | 0.00 | 0.29 | 0.42 |
還原基本平均股數(千股) | 55,864 | 55,465 | 55,149 | 54,978 | 54,801 | - | 54,608 | 54,502 | 54,380 | 54,104 |
還原稀釋平均股數(千股) | 55,864 | 56,464 | 56,016 | 55,724 | 55,626 | - | 54,608 | 54,502 | 62,454 | 62,087 |
EBITDA(千元) | 13,478 | 44,553 | 66,011 | 46,657 | 22,886 | 23,393 | 31,814 | 4,647 | 30,599 | 58,131 |